We also demonstrated that HRD1 alleviated neuronal cell death in a cellular model of PD using 6-hydroxydopamine (6-OHDA), which is widely used in in vitro and in vivo models of PD (Hernandez-Baltazar et al., 2017; Salari and Bagheri, 2019). Here, SYVN1 is linked to Parkinson disease.